543332 Stock Overview
Epigral Limited manufactures and sells chlor-alkali and related derivatives in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 2/6 |
Epigral Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹1,343.95 |
| 52 Week High | ₹1,438.75 |
| 52 Week Low | ₹870.00 |
| Beta | -0.39 |
| 1 Month Change | 26.86% |
| 3 Month Change | 34.66% |
| 1 Year Change | 41.29% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 231.31% |
Recent News & Updates
Recent updates
Shareholder Returns
| 543332 | IN Chemicals | IN Market | |
|---|---|---|---|
| 7D | 3.8% | 1.9% | 1.4% |
| 1Y | 41.3% | 18.9% | 46.1% |
Return vs Industry: 543332 exceeded the Indian Chemicals industry which returned 18.9% over the past year.
Return vs Market: 543332 underperformed the Indian Market which returned 46.1% over the past year.
Price Volatility
| 543332 volatility | |
|---|---|
| 543332 Average Weekly Movement | 7.4% |
| Chemicals Industry Average Movement | 6.5% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 543332's share price has been volatile over the past 3 months.
Volatility Over Time: 543332's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 936 | Kaushal Soparkar | epigral.com |
Epigral Limited manufactures and sells chlor-alkali and related derivatives in India and internationally. The company offers chlorinated polyvinyl chloride (CPVC) resins, epichlorohydrin, chloromethanes, hydrogen peroxide, caustic soda, chlorine, hydrogen, and caustic potash products. It also trades in agrochemical products.
Epigral Limited Fundamentals Summary
| 543332 fundamental statistics | |
|---|---|
| Market cap | ₹56.13b |
| Earnings (TTM) | ₹1.96b |
| Revenue (TTM) | ₹19.29b |
28.6x
P/E Ratio2.9x
P/S RatioIs 543332 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 543332 income statement (TTM) | |
|---|---|
| Revenue | ₹19.29b |
| Cost of Revenue | ₹11.67b |
| Gross Profit | ₹7.63b |
| Other Expenses | ₹5.67b |
| Earnings | ₹1.96b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 47.13 |
| Gross Margin | 39.53% |
| Net Profit Margin | 10.15% |
| Debt/Equity Ratio | 76.8% |
How did 543332 perform over the long term?
See historical performance and comparison